Percutaneous Coronary InterventionNCT07607522
Cardiac Rehab Referral Nudges
An observational study of Percutaneous Coronary Intervention and Valve Repair/Replacement, run by NYU Langone Health at 1 site in United States.
Trial summary
Investigators will evaluate the effectiveness of two different EHR-embedded nudges to improve referral to cardiac rehabilitation. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Percutaneous Coronary Intervention, Valve Repair/Replacement, Coronary Artery Bypass Grafting
- What is being tested?
- EHR Nudges
- How many people
- 7,000 participants
- Where
- 1 siteUnited States
- Study dates
- 15 Jun 2026to 15 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients seen by a cardiology provider in the ambulatory setting.
Who may be able to join
- Age of at least 18 years
- History of Coronary Artery Bypass Grafting (CABG), Percutaneous Coronary Intervention (PCI), or valve repair/replacement in the past year
Who cannot join
- Hospice
- Active home health
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Amrita Mukhopadhyay contact
Marine Nimblette contact
About this study
Investigators will evaluate the effectiveness of two different EHR-embedded nudges to improve referral to cardiac rehabilitation.
- Conditions
- Percutaneous Coronary Intervention, Valve Repair/Replacement, Coronary Artery Bypass Grafting
- Being tested
- EHR Nudges
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
EHR NudgesOther
Two types of nudges: 1) an auto pended bot order for cardiac rehab referral, 2) an EHR-embedded alert prompting cardiac rehab referral
| Study group | Role | What they receive |
|---|---|---|
| EHR Nudges | Two electronic health record (EHR)-embedded nudges will be deployed: 1) an auto pended bot order for cardiac rehab referral, 2) an EHR-embedded alert prompting cardiac rehab referral. Receives: Other: EHR Nudges | |
| Usual Care | Participants in the control group will not receive the auto pended bot order or the alert. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of patients eligible for cardiac rehab referral who are referred for cardiac rehab
Measured: Baseline
Secondary outcomes (1)
Percentage of patients who attend cardiac rehab
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 May 2026
- Study start15 Jun 2026 (estimated)
- Primary completion15 Sep 2026 (estimated)
- Study completion15 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Percutaneous Coronary InterventionStudies of the same condition, open and under way.
- More trials run by NYU Langone HealthThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 7,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- NYU Langone Health
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Amrita Mukhopadhyay, Principal investigator, NYU Langone Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07607522
- Sponsor's protocol ID
- QI-Cardiac Referral Nudge
- Status last verified
- May 2026
- First submitted
- 19 May 2026
- Last updated
- 26 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: This is a quality improvement (QI) project and individual participant data (IPD) will not be shared with other researchers.
Study at a glance
From the registry record, last updated by the sponsor on 26 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cardiac Rehab Referral Nudges
- ClinicalTrials.gov ID
- NCT07607522
- Acronym / sponsor ID
- QI-Cardiac Referral Nudge
- Conditions
- Percutaneous Coronary Intervention, Valve Repair/Replacement, Coronary Artery Bypass Grafting
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 7,000 participants (estimated)
- Lead sponsor
- NYU Langone HealthUniversity, hospital or other
- Study start
- 15 Jun 2026 (estimated)
- Primary completion
- 15 Sep 2026 (estimated)
- Study completion
- 15 Dec 2026 (estimated)
- First posted
- 26 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Investigators will evaluate the effectiveness of two different EHR-embedded nudges to improve referral to cardiac rehabilitation.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| EHR Nudges | – | Other: EHR NudgesTwo electronic health record (EHR)-embedded nudges will be deployed: 1) an auto pended bot order for cardiac rehab referral, 2) an EHR-embedded alert prompting cardiac rehab referral. |
| Usual Care | – | –Participants in the control group will not receive the auto pended bot order or the alert. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients seen by a cardiology provider in the ambulatory setting.
Key inclusion criteria (2 listed)
- Age of at least 18 years
- History of Coronary Artery Bypass Grafting (CABG), Percutaneous Coronary Intervention (PCI), or valve repair/replacement in the past year
Key exclusion criteria (2 listed)
- Hospice
- Active home health
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| EHR NudgesTwo types of nudges: 1) an auto pended bot order for cardiac rehab referral, 2) an EHR-embedded alert prompting cardiac rehab referral | Other | EHR Nudges |
Primary outcome
Percentage of patients eligible for cardiac rehab referral who are referred for cardiac rehab
Time frame: Baseline
1 secondary outcome
Percentage of patients who attend cardiac rehab
Time frame: Day 1
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 May 2026.
- Individual participant dataSharing planned: No. This is a quality improvement (QI) project and individual participant data (IPD) will not be shared with other researchers.
Related trials for Percutaneous Coronary Intervention
Not yet recruiting
Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI (TARGET-CHD)
Coronary Artery Disease, Atherosclerotic Cardiovascular Disease (ASCVD)
RecruitingPhase 4
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Acute Coronary Syndromes, STEMI
Not yet recruiting
ADVA ACE Coronary Stent System in Coronary Artery Disease Patients (ADVANCE)
Coronary Artery Disease, De Novo Stenosis Lesion
Recruiting
Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions
Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors
RecruitingPhase 3
Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI
Coronary Artery Disease (CAD), Percutaneous Coronary Intervention (PCI)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Amrita Mukhopadhyay contact
Marine Nimblette contact
Amrita Mukhopadhyay principal investigator
NYU Langone Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Percutaneous Coronary Intervention and Valve Repair/Replacement, run by NYU Langone Health at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 26 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Amrita Mukhopadhyay (amrita.mukhopadhyay@nyulangone.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of patients eligible for cardiac rehab referral who are referred for cardiac rehab (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2026.